Baird Maintains Outperform on Cardinal Health, Raises Price Target to $274

Cardinal Health, Inc.

Cardinal Health, Inc.

CAH

0.00

Baird analyst Eric Coldwell maintains Cardinal Health (NYSE: CAH) with a Outperform and raises the price target from $251 to $274.